Northwestern University School of Medicine in 1897 and trained in pathology at Rush Medical College, where his research focused on blastomycosis [2] . Before joining Ludvig Hektoen at The University of Chicago in 1902, Ricketts studied in Berlin, Vienna, and Paris for a year, enhancing his knowledge of both the concepts and laboratory methods of microbiology. The publication of his Infection, Immunity, and Serum Therapy [3] in 1906 established his credentials as a creative young scientist in infectious diseases. His goal was to address the muddled problem of Rocky Mountain spotted fever independently and with an open mind.
Funded by a small grant from the American Medical Association and by private funds, Ricketts arrived in Missoula, Montana, in late April 1906 and set up tents for his laboratory and housing, on the grounds of Northern Pacific Hospital [4] . His investigations during that year revealed most of the important principles related to rickettsiae (in particular, Rickettsia rickettsii) and to Rocky Mountain spotted fever. Ricketts had published 3 other reports [5] [6] [7] on different aspects of his research, before his article "Observations on the Virus and Means of Transmission of Rocky Mountain Spotted Fever" [8] was published in the Journal in 1907. These earlier articles, summarized in the introduction to the 1907 volume, described experimental transmission of the infection from the blood of patients to guinea pigs and monkeys, maintenance of the agent via serial animal passages alternating between monkeys and guinea pigs, and the ability of a female tick to acquire the infection by feeding on an experimentally infected guinea pig and to subsequently transmit the illness by feeding on another guinea pig. The latter phenomenon was simultaneously reported by King [9] , with whom Ricketts had shared his ideas and materials [5] [6] [7] 9] . Ricketts also reported in those first 3 articles preliminary observations regarding the nonfilterability of the agent; the occurrence of disseminated infections in humans and in experimentally infected animals; strong, active immunity in convalescent monkeys and guinea pigs; and the life cycle of the vector tick. No protozoa were observed in the blood of patients or of experimentally infected animals. The state of knowledge of Rocky Mountain spotted fever at the end of 1906 had been remarkably advanced in less than a year's time.
Ricketts' fourth article, submitted in December 1906 for publication in the Journal, attempted to tackle the nature of the infectious agent by evaluating its possible exclusive or dominant intraerythrocytic location [8] . Pursuing Wilson and Chowning's prior claim of the existence of an intraerythrocytic protozoon, Ricketts washed infected blood cells 10-12 times, decreasing but not eliminating the agent. By the 10th washing, nearly all of the infectious agent was associated with the cells. The remaining organisms either were intracellular or were firmly attached to blood cells. Conversely, serum was infectious even after 6 h of centrifugation. Clearly, extracellular organisms were also present. Their removal by passage of serum through a Berkefeld filter indicated that the agent should be visible microscopically-that is, that it should be bacterial, protozoal, or fungal. It was then known that some agents, known now as viruses, passed through Berkefeld filters. However, our contemporary concept of viruses did not then exist; "virus" was used merely to refer to an infectious agent, much as one today would refer to a "germ." As had been previously observed by Wilson and Chowning, Ricketts confirmed that bacterial cultures did not grow an agent from samples obtained from patients or from experimentally infected animals, a finding that was inconsistent with the era's thinking about ordinary bacterial agents.
Ricketts had discovered a novel category of pathogen, obligately intracellular bacterium. Later he would see small diplobacilli in infected blood, but his description of them was cautious, possibly because of Wilson and Chowning's erroneous microscopic identification of protozoa [10] . Ricketts' attempt to fulfill Koch's postulates was thwarted by the inability to cultivate these obligately intracellular bacteria [11] . Our contemporary interpretation of these experiments by Ricketts would be that he demonstrated that some rickettsiae are released from infected endothelial cells into the bloodstream, as extracellular bacteria, whereas other rickettsiae circulate in detached, infected endothelial cells and in mononuclear cells [12] . That Ricketts was able to characterize these organisms at all is remarkable, because (1) the vast majority reside in endothelial cells lining the blood vessels, (2) they spread by host-cell actin-based mobility directly from cell to cell, and (3) very few (median, 0.6 pfu/mL) are present in the blood-so few that even polymerase chain reaction often fails to detect their presence [13] [14] [15] [16] .
Ricketts' experiments in which red blood cells were ground up in an attempt to elucidate a potential intraerythrocytic infection were inconclusive. The preparations of lysed red blood cells were toxic and not very infectious. Ricketts' speculative interpretation of the possible "liberation of poisons by the crushing of the virus" (p. 150) illustrates the peril of trying to make too much of an inconclusive experiment.
The remainder of Ricketts' 1907 article catalogs the rest of his unpublished data for the year. He documented the transmission of rickettsiae by the male tick, and he described a method for continuous passage of the agent from guinea pig to guinea pig, by determining the peak period of infection and by harvesting tissue and blood samples at this earlier time rather than just before the animal died. In addition, Ricketts defined the heating and drying conditions that result in the loss of viability of the organisms and elucidated the kinetics of the slow loss of viability of rickettsiae stored in an ice chest.
The footnote to table 1 in Ricketts' 1907 paper describes one of his most important discoveries in 1906: the gross pathology of experimentally infected guinea pigs, including "hemorrhages into the skin of the external genitalia, and, in males, into the testicles and their coverings" (p. 144). For the first time there was a definitive, objective laboratory method for the diagnosis of Rocky Mountain spotted fever and for the detection of the presence of the etiologic agent in ecologic as well as clinical samples. Even before Flexnerian reforms in medical education, astute clinicians of the American West had noted that the disease was quite similar to typhus, but confusion abounded because its signs and symptoms were similar to those of other diseases. With Ricketts' findings, Rocky Mountain spotted fever became a true disease, not a syndrome. The macroscopic changes in infected guinea pigs yielded a distinctive criterion for the diagnosis of the infection.
AN EPILOGUE: RICKETTS' DISCOVERIES FROM 1907 TO 1910
Ricketts devoted the remainder of his life-a life that ended because of laboratory-acquired typhus fever in Mexico City in May 1910, only 4 years after he first set foot in western Montana [2] -to the study of what are now known as "rickettsioses." Recognizing that the agent of Rocky Mountain spotted fever resided in nature, he devoted much effort to elucidating its niche, with the aim of developing an approach to control the disease. He determined that vector ticks transmit the agent via their eggs to the next generation, and he documented the maintenance of the agent as a larva molts, after its blood meal, to become a nymph and, subsequently, as the nymph molts, after its blood meal, to become an adult male or female tick. He recognized early and proved definitively that transmission was biological, not merely mechanical. Part of the transmission-bytick hypothesis proposed by Wilson and Chowning was based on the scientific dogma of the time-that arthropods biologically transmit only parasites, examples being the transmission of the Texas cattle fever agent by ticks and of the filariasis and malaria agents by mosquitoes; in contrast, arthropods were thought to transmit bacteria only mechanically. Stiles rejected the protozoal etiology equally for its heretical transmission-bytick hypothesis and for the absence of protozoa in blood smears. Ricketts' experimental data, along with others' later studies of plague, typhus, tularemia, borrelioses, and bartonelloses, contributed to the downfall of this dogma.
During his studies of R. rickettsii in ticks, Ricketts observed small bacilli that were microscopically similar to what he had observed in infected blood. Using these tick-derived organisms, he developed an agglutination test that demonstrated antibodies in convalescent sera with reciprocal titers as high as 1:320. Nonimmune sera did not agglutinate the tick-associated bacteria-further evidence for a bacterial etiology and a tick host.
Ricketts' later discovery of tick-associated bacteria that were similarly agglutinated by immune sera but that did not cause infection in guinea pigs puzzled him. Of course, he was unaware of the existence of genetically related but nonpathogenic rickettsiae, such as R. peacockii and R. montanensis, that share antigens with R. rickettsii. Indeed, the high prevalence of R. peacockii on the eastern side of the Bitterroot River competitively excluded the establishment of transovarian transmission of R. rickettsii by ticks, explaining the data assembled by Wilson and Chowning that showed that Rocky Mountain spotted fever occurred only on the western side of the river [17, 18] . Ricketts' definitive proof of the importance of ticks in the maintenance of R. rickettsii was his demonstration that infected ticks existed in nature. The low percentage of ticks that carry R. rickettsii explained the fact that a large number of tick bites resulted in a relatively small number of infections. Only much later was it recognized that R. rickettsii is also mildly virulent for ticks, the most likely explanation for the low proportion of infected ticks in nature [19] .
Ricketts also investigated the possibility that a mammalian host might play a role in the maintenance of R. rickettsii in nature [4] . Columbian ground squirrels, chipmunks, and woodchucks were shown to be susceptible to an R. rickettsii bacteremia that, while relatively short in duration, was present at levels high enough to infect feeding ticks. Efforts to control the disease by the reduction of the populations of ticks and mammalian hosts have been difficult and have potentially harmful effects.
The final aspect of Rocky Mountain spotted fever to which Ricketts contributed was immunology. He demonstrated passive serum prophylaxis of experimental disease in guinea pigs, but, of 9 human patients treated with hyperimmune horse serum, 6 died [2, 20] . We now know, of course, that treatment with antibodies given late in the course of infection has little effect on the outcome [21] . Ricketts also utilized serovaccination in guinea pigs; the appropriate quantity of antibody modified the effect that an appropriate dose of R. rickettsii had on the stimulation of immunity. The tricky problem was establishing conditions that were uniformly effective and never fatal.
RICKETTS' LEGACY AND UNRESOLVED PROBLEMS OF RICKETTSIOLOGY
Ricketts' investigations were of long-lasting significance. The impact of his discovery of the first vector-borne obligately intracellular bacterium is emphasized in the names that were eventually applied to the genus, "Rickettsia"; the species, "rickettsii"; vector-borne obligately intracellular bacteria, "rickettsiae"; and a branch of microbiology, "rickettsiology." This welleducated, dedicated, hardworking man with a microscope; some guinea pigs, monkeys, and ticks; and only a few assistants began the demonstration that uncultivated, obligately intracellular bacteria cause many diseases. Furthermore, Ricketts did so under conditions rather foreign to scientists today. In 1906, Rocky Mountain spotted fever was a terrifying emerging infectious disease. Many workers, particularly in the preantibiotic era, died of laboratory-acquired R. rickettsii infection, and Ricketts died of infection from a related dangerous pathogen, R. prowazekii. It was equivalent to performing Ebola-virus research without protective laminar-flow safety cabinets, biosaftey level 3 and 4 laboratories, or such tools as cell culture, polymerase chain reaction, DNA sequencing, and electron microscopy. Yet, even as recently as the prolonged search for the cause of Legionnaire's disease, it was the guinea pig inoculation of infected human tissues, performed by a rickettsiologist, Joseph McDade, that first recovered the disease's etiologic agent, Legionella pneumophila [22] . It is curious that the many rickettsial agents discovered recently as the causes of emerging infectious diseases-agents such as R. japonica, R. honei, R. felis, R. africae, Ehrlichia chaffeensis, E. ewingii, E. muris, and Anaplasma phagocytophilum-have not attracted as much attention and scientific effort as have the many newly discovered pathogenic viruses; nor has antibiotic-resistant R. prowazekii received as much concern as have many less-pathogenic agents that have potential for dispersal by bioterrorists [23] [24] [25] [26] .
The list of unanswered questions regarding rickettsiae is longer today than it was in 1910. In the realm of how rickettsiae actually cause disease, significant unanswered questions include the following:
• What are the adhesins by which rickettsiae first attach to endothelial cells?
• What molecular mechanism(s) mediate rickettsial escape from the phagosome into the cytosol?
• What is the importance, in animal models and in human infections, of the R. rickettsii injury to endothelial cells that is caused by the stimulation of endothelial-cell production of reactive-oxygen species that has been characterized in vitro?
• What other rickettsia-mediated mechanisms of cell and tissue injury, including the activities of rickettsial proteases and phospholipases, occur in rickettsial diseases?
• What is the role that host-mediated mechanisms, such as the activities of cytokines and cytotoxic T lymphocytes, play in the pathogenesis of tissue injury?
• What are the molecular and cellular mechanisms that cause increased vascular permeability, the hallmark pathophysiologic effect of rickettsioses?
To develop an effective vaccine against rickettsiae, the following must be determined:
• The role and mechanisms of innate immunity to rickettsiae, including the identification of the initially infected cells (i.e., macrophages, dendritic cells, endothelium, or dermal fibroblasts) and of the most effective antigenpresenting cells;
• The effects of tick inoculation (i.e., immunomodulatory effects of tick saliva, the prolonged time course of inoculation, and the mechanism of rickettsial reactivation during tick feeding);
• The course and route of spread from the site of tick inoculation (i.e., rapid vs. local growth and slow spread; lymphatic vs. blood vessels);
• The mechanisms responsible for perivascular emigration of immune CD4 and CD8 T lymphocytes and macrophages at sites of endothelial infection;
• Whether nitric oxide-, reactive-oxygen species-, or tryptophan degradation-dependent antirickettsial mechanisms are active and important in vivo in human rickettsioses;
• The immunodominant rickettsial antigens responsible for (1) stimulating CD4 and CD8 T lymphocytes to secrete protective cytokines, (2) stimulating protective antibodies other than anti-outer-membrane proteins A and B, and (3) CD8 cytotoxic T lymphocyte activity, which is associated with the clearance of rickettsiae from the endothelium;
• The mechanism and effects of rickettsial infection-associated transient immunosuppression;
• The location and mechanism of R. prowazekii survival as a latent infection-and the factors and mechanisms that reactivate latent typhus, leading to Brill-Zinsser disease.
Just as important is the list of yet-to-be-developed laboratory tools-for example, a genetic system for knocking out or substituting rickettsial genes so that effective vaccines can be developed and virulence factors can be elucidated, and an affordable, available, ultrasensitive, specific, timely, point-of-care diagnostic test for rickettsial diseases in the acute stage.
It is a tragedy that Ricketts died in 1910. He would not have solved all of these problems had he lived another 25 or 30 years, but he would have advanced our knowledge of rickettsial and other infectious diseases faster, and he would have stimulated and educated one or more generations of new infectious-diseases scientists who would have changed the world. Perhaps, as a result, someone would have noted that rickettsial diseases are not eliminated by the use of doxycycline. Optimistically, the availability of rickettsial genome-sequence information would have been exploited more effectively to unravel pathogenesis and immunity, rather than to detail the minutiae of phylogeny. Rickettsiology today needs an infusion of new blood, particularly of more scientists who understand, as Ricketts did, infectious diseases and microbial pathogenesis.
